Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |